NCT07248839: A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment

Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Healthy Volunteers, Hepatic Impairment